Rapid Micro Biosystems, Inc. (RPID), a life sciences technology company, Friday announced that net loss narrowed in the fourth quarter, compared with the previous year.
Shares of Rapid Micro are dropping in the pre-market trading.
In the fourth quarter, net loss narrowed to $9.66 million from $11.16 million last year.
Loss per share were $0.22 versus $0.26 prior year.
Analysts, on average, had expected loss $0.22 per share. Analysts' estimates typically exclude special items.
Revenue for the quarter increased 30 percent to $8.22 million from $6.34 million in the previous year's quarter.
Full year 2025, the company expects to generate at least $32 million in revenue.
In the pre-market trading, Rapid Micro is 5.43% lesser at $3.33 on the Nasdaq.
For comments and feedback: editorial@rttnews.com